Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02305212 · ClinicalTrials.gov registry record · NA

Cogmed for Working Memory After TBI

A NA study, sponsored by Kessler Foundation.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT02305212 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02305212, a NA study, has completed, sponsored by Kessler Foundation.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This study will examine a cognitive rehabilitation protocol targeted at working memory deficits for adults and children with Traumatic Brain Injury (TBI). In this randomized clinical trial, the efficacy of Cogmed, a cognitive rehabilitation protocol designed to improve working memory, will be examined in children with TBI. Neuropsychological and daily life functioning will be measured. Participants will be children (N=20) and adults (N=20) with a documented history of TBI. Participants will be randomized to a treatment group or a wait list control group. The Experimental Group will receive the Cogmed working memory training program 30-40 minutes per day, 5 days a week for 5 weeks for a total training time of approximately 15 hours. The Control Group will be a wait list control group that will cross over into treatment after the follow-up assessment. All subjects will undergo repeat assessments following completion of the working memory training protocol after the 7th week and again at 13 weeks to document changes in working memory performance.

Interventions

  • BEHAVIORAL Cogmed

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2013-12
Est. Completion 2016-06-02
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT02305212

The ClinicalTrials.gov registry entry for NCT02305212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cogmed is the first listed.

NCT02305212 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02305212 about?

NCT02305212 is a clinical study titled "Cogmed for Working Memory After TBI". This study will examine a cognitive rehabilitation protocol targeted at working memory deficits for adults and children with Traumatic Brain Injury (TBI). In this randomized clinical trial, the efficacy of Cogmed, a cognitive rehabilitation protocol designed to improve working memory, will be examin...

What is the current status of trial NCT02305212?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2013-12. Estimated completion is 2016-06-02.

What interventions are being tested in trial NCT02305212?

The interventions under investigation include: Cogmed (BEHAVIORAL).

Who is sponsoring clinical trial NCT02305212?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.